Mimedx Group
MDXG· Manufacturing· Fiscal year ends in December· Structured data only: no proxy read yet
No proxy on file names the CEO of Mimedx Group.
Executives5
See all- 1Doug RiceNot disclosed
- 2Joseph CapperNot disclosed
- 3Kimberly Maersk-MollerNot disclosed
- 4Ricci S. WhitlowNot disclosed
- 5William F. Hulse IVNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Peers18
See allThe FY2025 (Dec) proxy of Mimedx Group names 18 peer companies for pay. Among Mimedx Group and these peers, CEO pay was 4th highest of 7 and total shareholder return was 5th highest of 7.
4th highest of 7in Mimedx Group and its pay peers, FY2025 (Dec) by CEO pay:
5th highest of 7in Mimedx Group and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board3
See all- K. Todd NewtonDirector · 6 yr on the boardIndependentCompensation (Chair), Ethics and Compliance—Paid as an executive
- Martin P. SutterDirector · 5 yr on the boardIndependentCompensation, Nominating and Corporate Governance (Chair)—Paid as an executive
- William A. HawkinsDirector · 5 yr on the boardIndependentEthics and Compliance (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Shared directors
- BiogenWilliam A. Hawkins1 shared
- BioventusWilliam A. Hawkins1 shared
Activity
No new filings about this company in the feed.
Filings6
See all| Proxy statement | DEF 14A | Apr 29, 2026 | FY2025 |
| Annual report | 10-K | Feb 25, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 30, 2025 | FY2024 |
| Annual report | 10-K | Feb 26, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 23, 2024 | FY2023 |
| Annual report | 10-K | Feb 28, 2024 | FY2023 |
